• Home Aeterna Zentaris presents two posters on perifosine at AACR meeting Aeterna Zentaris Inc.

Aeterna Zentaris presents two posters on perifosine at AACR meeting Aeterna Zentaris Inc.

Aeterna Zentaris President and Chief Executive Officer, commented, Gastric tumor represents a significant threat especially in Asia. This preclinical work demonstrates the potential of perifosine in combination with Xeloda for the treatment of gastric cancer especially. Furthermore, both posters are consistent with earlier data and the scientific observations emphasizing the advantage of merging perifosine with cytotoxic medications in different oncological indications. .. Aeterna Zentaris presents two posters on perifosine at AACR meeting Aeterna Zentaris Inc. Poster #1965: Entitled, Antitumor activity of novel Akt inhibitor, perifosine in gastric cell lines ,Tae Soo Kim, Hyo Melody Kim, Bo Ram Kwan, Chan Hee Recreation area, Hei-Cheul Jeung, Woo Ick Jang, Juergen Engel, Hyun Cheol Chung, Jae Kyung Roh, Sun Adolescent Rha, .Infectious complications in the first 100 days included several situations of bacterial infections at a rate that was anticipated after reduced-intensity conditioned HSCT . There have been no fungal or viral infections other than asymptomatic reactivation of cytomegalovirus. At 12 months, the cumulative incidence of relapse in recipients of maraviroc was 55.8 percent, which was not greater than expected considering the disease characteristics of the sufferers and the reduced-intensity conditioning regimen, which is connected with a high threat of relapse. A subset evaluation of patients with severe myeloid leukemia or the myelodysplastic syndromes and lymphoid cancers did not reveal any significant variations in relapse rates .